Bisphosphonates and osteonecrosis of the jaw

Journal of the American Geriatrics Society

Volumn 59, Issue 12, 2011, Pages 2350-2355

  Shannon, Jodi ^a   Shannon, John ^b   Modelevsky, Steven ^c   Grippo, Anne A ^d  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b JL Shannon Dentistry Arkansas   (United States)

^c Oral and Maxillofacial Surgery Arkansas   (United States)

^d ARKANSAS STATE UNIVERSITY   (United States)

Author keywords

bisphosphonates; cancer; jaw; osteonecrosis; osteoporosis

Indexed keywords

ACICLOVIR; ADENOSINE TRIPHOSPHATE; ALENDRONIC ACID; AMOXICILLIN; AZITHROMYCIN; BISPHOSPHONIC ACID DERIVATIVE; CHLORHEXIDINE; CLINDAMYCIN; CLODRONIC ACID; CLOTRIMAZOLE; ETIDRONIC ACID; FARNESYL DIPHOSPHATE; IBANDRONIC ACID; METRONIDAZOLE; NYSTATIN; PAMIDRONIC ACID; RISEDRONIC ACID; TILUDRONIC ACID; VALACICLOVIR; ZOLEDRONIC ACID;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BONE DENSITY; BONE METASTASIS; BREAST CANCER; CANCER INCIDENCE; CELL ACTIVATION; DENTAL PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG INFORMATION; DRUG MECHANISM; ESOPHAGITIS; ESOPHAGUS ULCER; GASTROINTESTINAL SYMPTOM; HUMAN; JAW OSTEONECROSIS; LUNG CANCER; MOUTH HYGIENE; MULTIPLE MYELOMA; NEPHROTOXICITY; NONHUMAN; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOPOROSIS; PATIENT EDUCATION; PRESCRIPTION; PROSTATE CANCER; QUALITY OF LIFE; RISK FACTOR; TOOTH IMPLANTATION; UNSPECIFIED SIDE EFFECT;

BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; DIPHOSPHONATES; HUMANS;

EID: 84155163782     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2011.03713.x     Document Type: Article

References (31)

1. American College of Rheumatology. Practice management: Osteoporosis [on-line]. Available at 2009 Accessed July 13, 2011.
2. Viera-Negron YE, Ruan W, Winger JN, et al. Effect of ovariectomy and alendronate on implant osseointegration in rat maxillary bone. J Oral Implantol 2008; 34: 76-82.
3. Saad F, Lipton A,. Clinical benefits and considerations of bisphosphonate treatment in metastatic bone disease. Semin Oncol 2007; 34 (Suppl 4): S17-S23. (Pubitemid 350192630)
4. Aapro MS,. Management of bisphosphonate treatment in clinical practice. Semin Oncol 2007; 34 (Suppl 4): S28-S32. (Pubitemid 350192626)
5. American Dental Association. Osteonecrosis of the jaw [on-line]. Available at (Dentist version) 2008 Accessed July 13, 2011.
6. American Dental Association Council on Scientific Affairs. Dental management of patients receiving oral bisphosphonate therapy. J Am Dent Assoc 2006; 137: 1144-1150.
7. Drake M, Clarke BL, Khosla S,. Bisphosphonates: Mechanism of action and role in clinical practice. Mayo Clin Proc 2008; 83: 1032-1045.
8. Medscape Medical News. Legal action on jaw necrosis from bisphosphonates [on-line]. Available at 2005 Accessed July 13, 2011.
9. National Osteoporosis Foundation. About osteoporosis [on-line]. Available at 2010 Accessed July 13, 2011.
10. Kimmel DB,. Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates. J Dent Res 2007; 86: 1022-1033.
11. Hellstein JW, Kalmar JR,. Osteoporosis medications and the risk of developing jaw complications. J Am Dent Assoc 2007; 138: 692.
12. Grant BT, Kraut RA,. Dental implants in geriatric patients: A retrospective study of 47 cases. Implant Dent 2007; 16: 362-368.
13. Edwards BK, Howe HL, Ries LAG, et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 2002; 94: 2766-2792. (Pubitemid 34478095)
14. Ruggiero S, Gralow J, Marx RE, et al. Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract 2006; 2: 7-14.
15. Carniero E, Vibhute P, Montazem A, et al. Bisphosphonate-associated mandibular osteonecrosis. Am J Neuroradiol 2006; 27: 1096-1097. (Pubitemid 44897693)
16. American Association of Oral and Maxillofacial Surgeons. Position paper on bisphosphonate-related osteonecrosis of the jaw, 2009 update [on-line]. Available at Accessed July 13, 2011.
17. Roelofs AJ, Thompson K, Gordon S, et al. Molecular mechanisms of action of bisphosphonates: Current status. Clin Cancer Res 2006; 12 (Suppl): 6222s-6230s. (Pubitemid 44703794)
18. Martin CK, Werbeck JL, Thudi NK, et al. Zolendronic acid reduces bone loss and tumor growth in an orthotoic xenograft model of osteolytic oral squamous cell carcinoma. Cancer Res 2010; 70: 8607-8616.
19. Odri GA, Dumoucel S, Gaelle P, et al. Zoledronic acid as a new adjuvant therapeutic strategy for Ewing's sarcoma patients. Cancer Res 2010; 70: 7610-7619.
20. Ottewell PD, Lefley DV, Coleman, et al. Evaluation of the molecular mechanisms for the sequence-dependent, synergistic anti-tumour effects of doxorubicin and zoledronic acid in breast cancer. Cancer Res 2009; 69 (2 Suppl): 722.
21. Cartsos VM, Zhu S, Zavras AI,. Bisphosphonate use and the risk of adverse jaw outcomes: A medical claims study of 714,217 people. J Am Dent Assoc 2008; 139: 23-30.
22. National Institute of Dental and Craniofacial Research. Bisphosphonate-associated osteonecrosis of the jaw: Pathophysiology and epidemiology [on-line]. Available at 2010 Accessed July 13, 2011.
23. Russell LA,. Bisphosphonates and osteonecrosis of the jaw. Hospital for Special Surgery [on-line]. Available at 2006 Accessed July 13, 2011.
24. Garvin J,. ADA resources answer bisphosphonate questions; "Research and treatment experience is moving quickly." Am Dent Assoc News [on-line]. Available at 2008 Accessed July 13, 2011.
25. Capsoni F, Longhi M, Weinstein R,. Bisphosphonate-associated osteonecrosis of the jaw: The rheumatologist's role. Arthritis Res Ther 2006; 8: 219-224.
26. Clarke B, Koka S,. Bisphosphonate-associated osteonecrosis of the jaw. American College of Rheumatology Hotline [on-line]. Available at 2006 Accessed July 13, 2011.
27. Sedghizadeh PP, Stanley K, Caligiuri M, et al. Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw. J Am Dent Assoc 2009; 140: 61-66.
28. National Institutes of Health, Department of Health and Human Services. Osteonecrosis [on-line]. Available at 2009 Accessed July 13, 2011.
29. Google search: Lawyers, osteonecrosis of the jaw, bisphosphonates [on-line]. Available at Accessed July 13, 2011.
30. Markiewicz MR, Margarone JE, Campbell JH, et al. Bisphosphonate- associated osteonecrosis of the jaws. J Am Dent Assoc 2005; 136: 1669-1674.
31. Damato K, Gralow J, Hoff A, et al. Expert panel recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaws. Novartis Pharmaceuticals Corporation [on-line]. Available at 2005 Accessed July 13, 2011.